Panbio Lifescience Systems Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 898.48%
(FY 2022)
- Profit 217.08%
(FY 2022)
- Ebitda 240.85%
(FY 2022)
- Net Worth 18.73%
(FY 2022)
- Total Assets 6.93%
(FY 2022)
About Panbio Lifescience Systems
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Sharma and Mamta Sharma serve as directors at the Company.
- CIN/LLPIN
U51909HR2017PTC068797
- Company No.
068797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Panbio Lifescience Systems Private Limited offer?
Panbio Lifescience Systems Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Apparatus, Heater, Thermostat & Heating Devices, Industrial Heaters, Pollution Control Devices & Machines, Industrial Air Filter, Water Treatment & Purification Plant, Water Purification Plants, Laboratory Cabinets, Industrial Furnaces & Ovens.
Who are the key members and board of directors at Panbio Lifescience Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Sharma  | Director | 26-Apr-2017 | Current |
| Mamta Sharma | Director | 26-Apr-2017 | Current |
Financial Performance of Panbio Lifescience Systems.
Panbio Lifescience Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 898.48% increase. The company also saw a substantial improvement in profitability, with a 217.08% increase in profit. The company's net worth Soared by an impressive increase of 18.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panbio Lifescience Systems?
Unlock access to Panbio Lifescience Systems's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Panbio Lifescience Systems?
Unlock and access historical data on people associated with Panbio Lifescience Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panbio Lifescience Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panbio Lifescience Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
